1. Davis FG, Kupelian V, Freels S, McCarthy B, Surawicz T. Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro-oncology. 2001 Jul 1;3(3):152-8. doi:10.1093/neuonc/3.3.152
2. Maness PF, Schachner M. Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration. Nature neuroscience. 2007 Jan;10(1):19-26. doi:10.1038/nn1827
3. Boo YJ, Park JM, Kim J, Chae YS, Min BW, Um JW, Moon HY. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer. Annals of surgical oncology. 2007 May;14(5):1703-11. doi: 10.1245/s10434-006-9281-8
4. Huszar M, Moldenhauer G, Gschwend V, Ben-Arie A, Altevogt P, Fogel M. Expression profile analysis in multiple human tumors identifies L1 (CD171) as a molecular marker for differential diagnosis and targeted therapy. Human pathology. 2006 Aug 1;37(8):1000-8. doi:10.1016/j.humpath.2006.03.014
5. Pechriggl EJ, Concin N, Blumer MJ, Bitsche M, Zwierzina M, Dudas J, Koziel K, Altevogt P, Zeimet AG, Fritsch H. L1CAM in the early enteric and urogenital system. Journal of Histochemistry & Cytochemistry. 2017 Jan;65(1):21-32. doi: 10.1369/0022155416677241
6. Schäfer MK, Altevogt P. L1CAM malfunction in the nervous system and human carcinomas. Cellular and molecular life sciences. 2010 Jul;67(14):2425-37. doi: 10.1007/s00018-010-0339-1
7. Siesser PF, Maness PF. L1 cell adhesion molecules as regulators of tumor cell invasiveness. Cell adhesion & migration. 2009 Jul 1;3(3):275-7. doi: 10.4161/cam.3.3.8689
8. Riedle S, Kiefel H, Gast D, Bondong S, Wolterink S, Gutwein P, Altevogt P. Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/γ-secretase activity. Biochemical Journal. 2009 Jun 15;420(3):391-402. doi: 10.1042/BJ20081625
9. Gavert N, Ben-Shmuel A, Raveh S, Ben-Ze'ev A. L1-CAM in cancerous tissues. Expert opinion on biological therapy. 2008 Nov 1;8(11):1749-57. doi:10.1517/14712598.8.11.1749
10. Yang M, Li Y, Chilukuri K, Brady OA, Boulos MI, Kappes JC, Galileo DS. L1 stimulation of human glioma cell motility correlates with FAK activation. Journal of neuro-oncology. 2011 Oct;105(1):27-44. doi: 10.1007/s11060-011-0557-x
11. Skwarczynski M, Toth I. Recent advances in peptide-based subunit nanovaccines. Nanomedicine. 2014 Dec;9(17):2657-69. doi: 10.2217/nnm.14.187
12. Doytchinova IA, Flower DR. Quantitative approaches to computational vaccinology. Immunology and Cell Biology. 2002 Jun;80(3):270-9. doi: 10.1046/j.1440-1711.2002.01076.x
13. Flower DR, McSparron H, Blythe MJ, Zygouri C, Taylor D, Guan P, Wan S, Coveney P, Walshe V, Borrow P, Doytchinova IA. Computational vaccinology: quantitative approaches. InNovartis Foundation Symposium 2003 Jan 1 (pp. 102-125). Chichester; New York; John Wiley; 1999. doi: 10.1002/0470090766
14. Nezafat N, Ghasemi Y, Javadi G, Khoshnoud MJ, Omidinia E. A novel multi-epitope peptide vaccine against cancer: an in silico approach. Journal of theoretical biology. 2014 May 21;349:121-34. doi: 10.1016/j.jtbi.2014.01.018
15. Phongsisay V, Iizasa EI, Hara H, Yoshida H. Evidence for TLR4 and FcRγ–CARD9 activation by cholera toxin B subunit and its direct bindings to TREM2 and LMIR5 receptors. Molecular immunology. 2015 Aug 1;66(2):463-71. doi: 10.1016/j.molimm.2015.05.008
16. Geer LY, Marchler-Bauer A, Geer RC, Han L, He J, He S, Liu C, Shi W, Bryant SH. The NCBI biosystems database. Nucleic acids research. 2010 Jan 1;38(suppl_1):D492-6. doi: doi.org/10.1093/nar/gkp858
17. Krogh A, Larsson B, Von Heijne G, Sonnhammer EL. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. Journal of molecular biology. 2001 Jan 19;305(3):567-80. doi: 10.1006/jmbi.2000.4315
18. Nair DT, Singh K, Siddiqui Z, Nayak BP, Rao KV, Salunke DM. Epitope recognition by diverse antibodies suggests conformational convergence in an antibody response. The Journal of Immunology. 2002 Mar 1;168(5):2371-82. doi: 10.4049/jimmunol.168.5.2371
19. Jespersen MC, Peters B, Nielsen M, Marcatili P. BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic acids research. 2017 Jul 3;45(W1):W24-9. doi: 10.1093/nar/gkx346
20. Zhang Q, Wang P, Kim Y, Haste-Andersen P, Beaver J, Bourne PE, Bui HH, Buus S, Frankild S, Greenbaum J, Lund O. Immune epitope database analysis resource (IEDB-AR). Nucleic acids research. 2008 May 31;36(suppl_2):W513-8. doi: 10.1093/nar/gkn254
21. Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC bioinformatics. 2007 Dec;8(1):1-7. doi: 10.1186/1471-2105-8-4
22. Bui HH, Sidney J, Li W, Fusseder N, Sette A. Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC bioinformatics. 2007 Dec;8(1):1-6. doi: 10.1186/1471-2105-8-361
23. Dimitrov I, Bangov I, Flower DR, Doytchinova I. AllerTOP v. 2—a server for in silico prediction of allergens. Journal of molecular modeling. 2014 Jun;20(6):1-6. doi: 10.1007/s00894-014-2278-5
24. Dimitrov I, Naneva L, Doytchinova I, Bangov I. AllergenFP: allergenicity prediction by descriptor fingerprints. Bioinformatics. 2014 Mar 15;30(6):846-51. doi: 10.1093/bioinformatics/btt619
25. Gupta S, Kapoor P, Chaudhary K, Gautam A, Kumar R, Raghava GP, Open Source Drug Discovery Consortium. In silico approach for predicting toxicity of peptides and proteins. PloS one. 2013 Sep 13;8(9):e73957.
26. Khatoon N, Pandey RK, Prajapati VK. Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach. Scientific reports. 2017 Aug 15;7(1):1-2. doi: 10.1038/s41598-017-08842-w
27. Baldauf KJ, Royal JM, Hamorsky KT, Matoba N. Cholera toxin B: one subunit with many pharmaceutical applications. Toxins. 2015 Mar;7(3):974-96. doi: 10.3390/toxins7030974
28. Gasteiger E, Hoogland C, Gattiker A, Wilkins MR, Appel RD, Bairoch A. Protein identification and analysis tools on the ExPASy server. The proteomics protocols handbook. 2005:571-607. doi: 10.1385/1-59259-890-0:571
29. Lear S, Cobb SL. Pep-Calc. com: a set of web utilities for the calculation of peptide and peptoid properties and automatic mass spectral peak assignment. Journal of computer-aided molecular design. 2016 Mar 1;30(3):271-7. doi: 10.1007/s10822-016-9902-7
30. Buchan DW, Minneci F, Nugent TC, Bryson K, Jones DT. Scalable web services for the PSIPRED Protein Analysis Workbench. Nucleic acids research. 2013 Jul 1;41(W1):W349-57. doi: 10.1093/nar/gkt381
31. Wang S, Peng J, Ma J, Xu J. Protein secondary structure prediction using deep convolutional neural fields. Scientific reports. 2016 Jan 11;6(1):1-1. doi: 10.1038/srep18962
32. Roy A, Kucukural A, Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nature protocols. 2010 Apr;5(4):725-38. doi: 10.1038/nprot.2010.5
33. DeLano WL. Pymol: An open-source molecular graphics tool. CCP4 Newsletter on protein crystallography. 2002 Mar;40(1):82-92.
34. Lovell SC, Davis IW, Arendall III WB, De Bakker PI, Word JM, Prisant MG, Richardson JS, Richardson DC. Structure validation by Cα geometry: ϕ, ψ and Cβ deviation. Proteins: Structure, Function, and Bioinformatics. 2003 Feb 15;50(3):437-50. doi: 10.1002/prot.10286
35. Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic acids research. 2007 Jul 1;35(suppl_2):W407-10. 10.1093/nar/gkm290 doi: 10.1093/nar/gkm290
36. Grote A, Hiller K, Scheer M, Münch R, Nörtemann B, Hempel DC, Jahn D. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic acids research. 2005 Jul 1;33(suppl_2):W526-31. doi: 10.1093/nar/gki376
37. Morla S, Makhija A, Kumar S. Synonymous codon usage pattern in glycoprotein gene of rabies virus. Gene. 2016 Jun 10;584(1):1-6.doi: 10.1016/j.gene.2016.02.047
38. Ali M, Pandey RK, Khatoon N, Narula A, Mishra A, Prajapati VK. Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection. Scientific reports. 2017 Aug 23;7(1):1-3. doi: 10.1038/s41598-017-09199-w
39. Vajda S, Yueh C, Beglov D, Bohnuud T, Mottarella SE, Xia B, Hall DR, Kozakov D. New additions to the C lus P ro server motivated by CAPRI. Proteins: Structure, Function, and Bioinformatics. 2017 Mar;85(3):435-44. doi: 10.1002/prot.25219
40. Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, Beglov D, Vajda S. The ClusPro web server for protein–protein docking. Nature protocols. 2017 Feb;12(2):255. doi: 10.1038/nprot.2016.169
41. Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee SU. Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pacific journal of cancer prevention: APJCP. 2017;18(1):3. doi: 10.22034/APJCP.2017.18.1.3
42. Oh T, Fakurnejad S, Sayegh ET, Clark AJ, Ivan ME, Sun MZ, Safaee M, Bloch O, James CD, Parsa AT. Immunocompetent murine models for the study of glioblastoma immunotherapy. Journal of translational medicine. 2014 Dec;12(1):1-0. doi: 10.1186/1479-5876-12-107
43. Kindy MS, Yu J, Zhu H, Smith MT, Gattoni-Celli S. A therapeutic cancer vaccine against GL261 murine glioma. Journal of translational medicine. 2016 Dec;14(1):1-9. doi: 10.1186/s12967-015-0757-9
44. Moise L, Gutierrez A, Kibria F, Martin R, Tassone R, Liu R, Terry F, Martin B, De Groot AS. iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines. Human vaccines & immunotherapeutics. 2015 Sep 2;11(9):2312-21.doi:10.1080/21645515.2015.1061159
45. Zhou WY, Shi Y, Wu C, Zhang WJ, Mao XH, Guo G, Li HX, Zou QM. Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model. Vaccine. 2009 Aug 6;27(36):5013-9. doi: 10.1016/j.vaccine.2009.05.009
46. Tanaka Y, Wada H, Goto R, Osada T, Yamamura K, Fukaya S, Shimizu A, Okubo M, Minamiguchi K, Ikizawa K, Sasaki E. TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A* 2402 mice. Scientific reports. 2020 Oct 14;10(1):1-1.. doi: 10.1038/s41598-020-74187-6
47. Li X, Guo L, Kong M, Su X, Yang D, Zou M, Liu Y, Lu L. Design and evaluation of a multi-epitope peptide of human metapneumovirus. Intervirology. 2015;58(6):403-12. doi: 10.1159/000445059
48. Safavi A, Kefayat A, Sotoodehnejadnematalahi F, Salehi M, Modarressi MH. Production, purification, and in vivo evaluation of a novel multiepitope peptide vaccine consisted of immunodominant epitopes of SYCP1 and ACRBP antigens as a prophylactic melanoma vaccine. International immunopharmacology. 2019 Nov 1;76:105872. doi: 10.1016/j.intimp.2019.105872
49. Oloomi M, Javadi M, Karam MR, Khezerloo JK, Haghri Z, Bouzari S. Protective multi-epitope candidate vaccine for urinary tract infection. Biotechnology Reports. 2020 Dec 1;28:e00564. doi: 10.1016/j.btre.2020.e00564
50. Dawood RM, Moustafa RI, Abdelhafez TH, El-Shenawy R, El-Abd Y, El Din NG, Dubuisson J, El Awady MK. A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in mice. BMC infectious diseases. 2019 Dec;19(1):1-1. doi: 10.1186/s12879-019-4571-5
51. Guo L, Yin R, Liu K, Lv X, Li Y, Duan X, Chu Y, Xi T, Xing Y. Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB/c mice model. Applied microbiology and biotechnology. 2014 Apr;98(8):3495-507. doi: 10.1007/s00253-013-5408-6
52. Zhou WY, Shi Y, Wu C, Zhang WJ, Mao XH, Guo G, Li HX, Zou QM. Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model. Vaccine. 2009 Aug 6;27(36):5013-9. doi: 10.1016/j.vaccine.2009.05.009
53. Cao Y, Li D, Fu Y, Bai Q, Chen Y, Bai X, Jing Z, Sun P, Bao H, Li P, Zhang J. Rational design and efficacy of a multi-epitope recombinant protein vaccine against foot-and-mouth disease virus serotype A in pigs. Antiviral research. 2017 Apr 1;140:133-41. doi: 10.1016/j.antiviral.2017.01.023
54. Jiang P, Cai Y, Chen J, Ye X, Mao S, Zhu S, Xue X, Chen S, Zhang L. Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB/c mice model. Vaccine. 2017 May 25;35(23):3096-103. doi: 10.1016/j.vaccine.2017.04.031
55. Lennerz V, Gross S, Gallerani E, Sessa C, Mach N, Boehm S, Hess D, Von Boehmer L, Knuth A, Ochsenbein AF, Gnad-Vogt U. Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors. Cancer immunology, immunotherapy. 2014 Apr 1;63(4):381-94. doi: 10.1007/s00262-013-1516-5
56. Slingluff CL, Lee S, Zhao F, Chianese-Bullock KA, Olson WC, Butterfield LH, Whiteside TL, Leming PD, Kirkwood JM. A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602). Clinical Cancer Research. 2013 Aug 1;19(15):4228-38. doi: 10.1158/1078-0432.
57. Romeli S, Hassan SS, Yap WB. Multi-Epitope Peptide-Based and Vaccinia-Based Universal Influenza Vaccine Candidates Subjected to Clinical Trials. The Malaysian journal of medical sciences: MJMS. 2020 Mar;27(2):10. doi: 10.21315/mjms2020.27.2.2
58. Toledo H, Baly A, Castro O, Resik S, Laferté J, Rolo F, Navea L, Lobaina L, Cruz O, Mı́guez J, Serrano T. A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers. Vaccine. 2001 Jul 20;19(30):4328-36. doi: 10.1016/S0264-410X(01)00111-6
59. Ojha R, Pareek A, Pandey RK, Prusty D, Prajapati VK. Strategic development of a next-generation multi-epitope vaccine to prevent nipah virus zoonotic infection. ACS omega. 2019 Aug 7;4(8):13069-79. doi: 10.1021/acsomega.9b00944
60. Pandey RK, Bhatt TK, Prajapati VK. Novel immunoinformatics approaches to design multi-epitope subunit vaccine for malaria by investigating anopheles salivary protein. Scientific reports. 2018 Jan 18;8(1):1-1. doi:10.1038/s41598-018-19456-1
61. Kamthania M, Srivastava S, Desai M, Jain A, Shrivastav A, Sharma DK. Immunoinformatics Approach to design T-cell epitope-based vaccine against hendra virus. International Journal of Peptide Research and Therapeutics. 2019 Dec;25(4):1627-37. doi: 10.1007/s10989-018-09805-z
62. Ropón-Palacios G, Chenet-Zuta ME, Otazu K, Olivos-Ramirez GE, Camps I. Novel multi-epitope protein containing conserved epitopes from different Leishmania species as potential vaccine candidate: Integrated immunoinformatics and molecular dynamics approach. Computational biology and chemistry. 2019 Dec 1;83:107157. doi: 10.1016/j.compbiolchem.2019.107157
63. Moghri SA, Ranjbar M, Hassannia H, Khakdan F. Designing a Novel Multi-Epitope Vaccine against SARS-CoV-2; Implication for Viral Binds and Fusion Inhibition through Inducing Neutralizing Antibodies. bioRxiv. 2021 Jan 1.
64. Kowitz A, Kadmon G, Verschueren H, Remels L, De Baetselier P, Hubbe M, Schachner M, Schirrmacher V, Altevogt P. Expression of L1 cell adhesion molecule is associated with lymphoma growth and metastasis. Clinical & experimental metastasis. 1993 Sep 1;11(5):419-29. doi: 10.1007/BF00132985
65. Debiec H, Christensen EI, Ronco PM. The cell adhesion molecule L1 is developmentally regulated in the renal epithelium and is involved in kidney branching morphogenesis. The Journal of cell biology. 1998 Dec 28;143(7):2067-79. doi: 10.1083/jcb.143.7.2067
66. Gavert N, Ben-Shmuel A, Raveh S, Ben-Ze'ev A. L1-CAM in cancerous tissues. Expert opinion on biological therapy. 2008 Nov 1;8(11):1749-57. doi: 10.1517/14712598.8.11.1749
67. Meza B, Ascencio F, Sierra-Beltrán AP, Torres J, Angulo C. A novel design of a multi-antigenic, multistage and multi-epitope vaccine against Helicobacter pylori: an in silico approach. Infection, Genetics and Evolution. 2017 Apr 1;49:309-17. doi: 10.1016/j.meegid.2017.02.007